About Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology is a company based in Jing'an (China) founded in 2017 by Junlin Wang. Youlin Pharmaceutical Technology has raised $15.66 million across 1 funding round from investors including Bell Capital and Cenova. Youlin Pharmaceutical Technology offers products and services including Clinical Research Services and Data Management Services.
- Headquarter Jing'an, China
- Founders Junlin Wang
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name 上海有临医药科技有限公司
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$15.66 M (USD)
in 1 rounds
-
Latest Funding Round
$15.66 M (USD), Series A
Jun 03, 2021
-
Investors
Bell Capital
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology offers a comprehensive portfolio of products and services, including Clinical Research Services and Data Management Services.
Early and II-III phase clinical trials are conducted for various therapeutic areas
Data management and statistical analysis are provided for clinical trials using tools like TrialMaster
Funding Insights of Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology has successfully raised a total of $15.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.66 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $15.7M
-
First Round
First Round
(03 Jun 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series A - Youlin Pharmaceutical Technology | Valuation | Bell Capital |
Investors in Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bell Capital and Cenova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
Investments & Acquisitions by Youlin Pharmaceutical Technology
Financial Statements - Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology Comparisons
Competitors of Youlin Pharmaceutical Technology
Latest news on Youlin Pharmaceutical Technology
Frequently Asked Questions about Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Youlin Pharmaceutical Technology is headquartered in Jing'an, China. It is registered at Jing'an, Shanghai, China.
Junlin Wang is the current CEO of Youlin Pharmaceutical Technology. They have also founded this company.
Youlin Pharmaceutical Technology is a funded company, having raised a total of $15.66M across 1 funding round to date. The company's 1st funding round was a Series A of $15.66M, raised on Jun 03, 2021.
Youlin Pharmaceutical Technology laboratory focused on providing diversified services for development of innovative oncology drugs through providing healthcare solutions, and medical research labs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Youlin Pharmaceutical Technology offers Clinical Research Services and Data Management Services.
Youlin Pharmaceutical Technology has 2 investors. Key investors include Bell Capital, and Cenova.